More specifically, ApoE4 may inhibit Aβ clearance by competitively binding to the low-density lipoprotein receptor-related protein 1, and its presence has been associated with brain Αβ accumulation and increased AD risk. This evidence concerns the gene PPIB and Alzheimer disease.